Leyi Gu

1.9k total citations · 1 hit paper
43 papers, 1.2k citations indexed

About

Leyi Gu is a scholar working on Nephrology, Molecular Biology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Leyi Gu has authored 43 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Nephrology, 9 papers in Molecular Biology and 9 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Leyi Gu's work include Chronic Kidney Disease and Diabetes (12 papers), Dialysis and Renal Disease Management (11 papers) and Renal Diseases and Glomerulopathies (7 papers). Leyi Gu is often cited by papers focused on Chronic Kidney Disease and Diabetes (12 papers), Dialysis and Renal Disease Management (11 papers) and Renal Diseases and Glomerulopathies (7 papers). Leyi Gu collaborates with scholars based in China, Japan and United States. Leyi Gu's co-authors include Zhaohui Ni, Jiaqi Qian, Shan Mou, Huili Dai, Xinghua Shao, Ben He, Jianping Liu, Ling Wang, Qisheng Lin and Tomohito Gohda and has published in prestigious journals such as Molecular and Cellular Biology, The FASEB Journal and Free Radical Biology and Medicine.

In The Last Decade

Leyi Gu

38 papers receiving 1.2k citations

Hit Papers

Mitophagy alleviates cisplatin-induced renal tubular epit... 2023 2026 2024 2025 2023 40 80 120
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Mitophagy alleviates cisplatin-induced renal tubular epithelial cell ferroptosis through ROS/HO-1/GPX4 axis
    2023 129 citations Qisheng Lin, Haijiao Jin et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Leyi Gu China 15 602 364 154 154 130 43 1.2k
Jianwei Tian China 24 605 1.0× 506 1.4× 155 1.0× 154 1.0× 146 1.1× 66 1.5k
B. Gondouin France 16 659 1.1× 394 1.1× 144 0.9× 72 0.5× 85 0.7× 26 1.3k
Zongpei Jiang China 17 458 0.8× 363 1.0× 119 0.8× 250 1.6× 94 0.7× 62 1.3k
Ernesto Martín‐Núñez Spain 18 548 0.9× 310 0.9× 86 0.6× 99 0.6× 112 0.9× 51 1.2k
Atsuko Kamijo‐Ikemori Japan 19 643 1.1× 348 1.0× 86 0.6× 166 1.1× 187 1.4× 63 1.2k
Kausik Umanath United States 14 655 1.1× 301 0.8× 141 0.9× 86 0.6× 90 0.7× 27 1.4k
Masaru Motojima Japan 18 720 1.2× 373 1.0× 110 0.7× 86 0.6× 57 0.4× 30 1.2k
Aleksandar Sikole North Macedonia 18 504 0.8× 177 0.5× 168 1.1× 129 0.8× 93 0.7× 73 1.2k
Sydney Benchetrit Israel 18 441 0.7× 256 0.7× 132 0.9× 116 0.8× 124 1.0× 89 1.4k
Cristina Gluhovschi Romania 17 480 0.8× 164 0.5× 147 1.0× 93 0.6× 107 0.8× 85 976

Countries citing papers authored by Leyi Gu

Since Specialization
Citations

This map shows the geographic impact of Leyi Gu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Leyi Gu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Leyi Gu more than expected).

Fields of papers citing papers by Leyi Gu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Leyi Gu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Leyi Gu. The network helps show where Leyi Gu may publish in the future.

Co-authorship network of co-authors of Leyi Gu

This figure shows the co-authorship network connecting the top 25 collaborators of Leyi Gu. A scholar is included among the top collaborators of Leyi Gu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Leyi Gu. Leyi Gu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Liu, Ruijie, Zhengzhe Li, Leyi Gu, et al.. (2024). Targeting Krüppel-Like Factor 2 as a Novel Therapy for Glomerular Endothelial Cell Injury in Diabetic Kidney Disease. Journal of the American Society of Nephrology. 36(2). 193–204. 1 indexed citations
3.
4.
Shen, Jianxiao, Liang Ying, Wenyan Zhou, et al.. (2024). Integrative ATAC‐seq and RNA‐seq analysis associated with diabetic nephropathy and identification of novel targets for treatment by dapagliflozin. Cell Biochemistry and Function. 42(2). e3943–e3943.
5.
Jin, Haijiao, Yuanting Yang, Xuying Zhu, et al.. (2024). DDRGK1-mediated ER-phagy attenuates acute kidney injury through ER-stress and apoptosis. Cell Death and Disease. 15(1). 63–63. 12 indexed citations
6.
Che, Xiajing, Minfang Zhang, Chaojun Qi, et al.. (2024). The presence of exudative thickening of Bowman’s capsule predict poor prognosis in diabetic kidney disease. Diabetes Research and Clinical Practice. 209. 111594–111594.
7.
Cai, Hong, Jiayi Yan, Shang Liu, et al.. (2023). Paxlovid for hospitalized COVID-19 patients with chronic kidney disease. Antiviral Research. 216. 105659–105659. 12 indexed citations
8.
Yan, Jiayi, Xiaoqian Yang, Hong Cai, et al.. (2023). Metabolic Risk Profile and Graft Function Deterioration 2 Years After Kidney Transplant. JAMA Network Open. 6(12). e2349538–e2349538. 3 indexed citations
9.
Yu, Zanzhe, Li Ding, Jiaying Huang, et al.. (2023). An observational study on the effect of seasonal variation on peritoneal dialysis patients. Frontiers in Physiology. 14. 1172308–1172308. 1 indexed citations
10.
11.
Li, Ding, Hao Yan, Zhenyuan Li, et al.. (2023). Pharmacokinetics of Henagliflozin in Dialysis Patients with Diabetes. Clinical Pharmacokinetics. 62(11). 1581–1587. 3 indexed citations
12.
Cheng, Qian, et al.. (2023). P2X7R/AKT/mTOR signaling mediates high glucose-induced decrease in podocyte autophagy. Free Radical Biology and Medicine. 204. 337–346. 11 indexed citations
13.
Lin, Qisheng, Xinghua Shao, S. Li, et al.. (2023). HIF1α-BNIP3-mediated mitophagy protects against renal fibrosis by decreasing ROS and inhibiting activation of the NLRP3 inflammasome. Cell Death and Disease. 14(3). 200–200. 57 indexed citations
14.
15.
Shao, Xinghua, Na Jiang, Shan Mou, et al.. (2018). Caspase-11-mediated tubular epithelial pyroptosis underlies contrast-induced acute kidney injury. Cell Death and Disease. 9(10). 983–983. 112 indexed citations
16.
Chen, Ya, Wei Fang, Leyi Gu, et al.. (2017). The role of hemoglobin variability as a prognostic indicator in peritoneal dialysis patients: a retrospective descriptive study. International Urology and Nephrology. 50(1). 167–171. 4 indexed citations
17.
Xu, Weijia, Xinghua Shao, Lei Tian, et al.. (2014). Astragaloside IV Ameliorates Renal Fibrosis via the Inhibition of Mitogen-Activated Protein Kinases and Antiapoptosis In Vivo and In Vitro. Journal of Pharmacology and Experimental Therapeutics. 350(3). 552–562. 68 indexed citations
18.
Shao, Xinghua, et al.. (2014). Astragalosides IV inhibits high glucose-induced cell apoptosis through HGF activation in cultured human tubular epithelial cells. Renal Failure. 36(3). 400–406. 31 indexed citations
19.
Wang, Ling, Zhaohui Ni, Ben He, et al.. (2008). Urinary IL-18 and NGAL as Early Predictive Biomarkers in Contrast-Induced Nephropathy after Coronary Angiography. Nephron Clinical Practice. 108(3). c176–c181. 201 indexed citations
20.
Gu, Leyi, Shinji Hagiwara, Qiuling Fan, et al.. (2005). Role of receptor for advanced glycation end-products and signalling events in advanced glycation end-product-induced monocyte chemoattractant protein-1 expression in differentiated mouse podocytes. Nephrology Dialysis Transplantation. 21(2). 299–313. 100 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jianwei Tian Breakdown of academic impact, for papers by B. Gondouin Breakdown of academic impact, for papers by Zongpei Jiang Breakdown of academic impact, for papers by Ernesto Martín‐Núñez Breakdown of academic impact, for papers by Atsuko Kamijo‐Ikemori Breakdown of academic impact, for papers by Kausik Umanath Breakdown of academic impact, for papers by Masaru Motojima Breakdown of academic impact, for papers by Aleksandar Sikole Breakdown of academic impact, for papers by Sydney Benchetrit Breakdown of academic impact, for papers by Cristina Gluhovschi
Rankless by CCL
2026